[1]
Marjani, M., Fahimi, F., Sadr, M., Kazempour Dizaji, M., Moniri, A., Khabiri, S., Tabarsi, P. and Velayati, A.A. 2019. Evaluation of silymarin for management of anti-tuberculosis drug induced liver injury: a randomized clinical trial. Gastroenterology and Hepatology from Bed to Bench. 12, 2 (Mar. 2019), 138–142. DOI:https://doi.org/10.22037/ghfbb.v12i2.1562.